The effect of mindfulness-based cognitive therapy on sexual self-esteem in women with breast cancer after mastectomy: a randomized controlled trial.

Authors

Sareh Khosravi-Khorram, Parvaneh Mousavi, Maryam Gholamzadeh-Jofreh, Mohammad-Hosein Haghighizadeh

Published in

Journal of cancer survivorship : research and practice. Sep 11, 2026. Epub Sep 11, 2026.

Abstract

Mastectomy often leads to decreased sexual self-esteem in women with breast cancer. This study aimed to evaluate the effect of Mindfulness-Based Cognitive Therapy (MBCT) on sexual self-esteem in women after mastectomy.
This randomized controlled trial (February-May 2024, Golestan Hospital, Ahvaz, Iran) enrolled 45 women aged 30-49 years after mastectomy. They were randomly assigned to an MBCT group (n = 22, eight weekly sessions) or a control group (n = 23, usual care). Sexual self-esteem was measured using the SSEI‑W‑SF at baseline and post-intervention. Data were analyzed using t‑tests and ANCOVA.
No baseline differences were found between groups. Post-intervention, after controlling for confounders, the MBCT group showed significantly higher scores in total sexual self-esteem and subscales (attractiveness, experience/skills, control, adaptation) compared to controls (p < 0.001, η² = 0.786). Moral judgment improved within the MBCT group (p < 0.001), but no significant between-group difference was observed (p = 0.106). The mean sexual self-esteem score was significantly higher in the MBCT group (145.95 ± 8.15) than controls (124.34 ± 10.09; p < 0.001). ANCOVA confirmed the intervention effect.
MBCT significantly improves sexual self-esteem and its components in women post-mastectomy. Integrating MBCT into survivorship care may address an overlooked aspect of breast cancer recovery.
MBCT is an effective non-pharmacological intervention for improving sexual self-esteem in women after mastectomy, enhancing their quality of life.
IRCT20231128060209N1 (registered February 5, 2024).

PMID:
42726155
Bibliographic data and abstract were imported from PubMed on 12 Sep 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.